541 studies found for: Open Studies | "Pancreatic Neoplasms"
Exceptional Responders With Pancreatic Cancer to Chemotherapy
Institut Paoli-Calmettes Pancreatic Neoplasms Database
Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
|5||Not yet recruiting||
Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer
Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Analgesia and Pancreatic Cancer Surgery
A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
SBRT Pre-operatively for Borderline Resectable Pancreatic Cancer
Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer
† Study has passed its completion date and status has not been verified in more than two years.